90 related articles for article (PubMed ID: 17919381)
1. [The relationship between resistin and the peripheral neuropathy in type 2 diabetes].
Wang XH; Wang DQ; Chen SH; Zhang L; Ni YH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1755-7. PubMed ID: 17919381
[TBL] [Abstract][Full Text] [Related]
2. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
3. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
4. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between the serum ET and resistin concentration and the peripheral neuropathy in type 2 diabetes].
Wang LM; Wang CX; Zhang DM; Xie YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):564-5, 567. PubMed ID: 21796841
[TBL] [Abstract][Full Text] [Related]
6. Serum resistin in acute myocardial infarction patients with and without diabetes mellitus.
Korah TE; Ibrahim HH; Badr EA; ElShafie MK
Postgrad Med J; 2011 Jul; 87(1029):463-7. PubMed ID: 21447495
[TBL] [Abstract][Full Text] [Related]
7. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
Osawa H; Ochi M; Tabara Y; Kato K; Yamauchi J; Takata Y; Nishida W; Onuma H; Shimizu I; Fujii Y; Miki T; Ohashi J; Makino H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):74-80. PubMed ID: 18081734
[TBL] [Abstract][Full Text] [Related]
8. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?
Afsar B; Sezer S; Elsurer R; Ozdemir FN
Blood Press Monit; 2007 Jun; 12(3):133-9. PubMed ID: 17496462
[TBL] [Abstract][Full Text] [Related]
9. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
10. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
11. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes.
Osawa H; Ochi M; Kato K; Yamauchi J; Nishida W; Takata Y; Kawamura R; Onuma H; Takasuka T; Shimizu I; Fujii Y; Ohashi J; Makino H
Biochem Biophys Res Commun; 2007 Apr; 355(2):342-6. PubMed ID: 17303077
[TBL] [Abstract][Full Text] [Related]
12. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
Al-Sari IE; Al-Quobaili FA; Kabalan YM
Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
[TBL] [Abstract][Full Text] [Related]
13. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.
Schäffler A; Büchler C; Müller-Ladner U; Herfarth H; Ehling A; Paul G; Schölmerich J; Zietz B
Horm Metab Res; 2004 Oct; 36(10):702-7. PubMed ID: 15523596
[TBL] [Abstract][Full Text] [Related]
14. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
15. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
Habib SS
Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
[TBL] [Abstract][Full Text] [Related]
16. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
[TBL] [Abstract][Full Text] [Related]
17. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between serum resistin level and large arterial elasticity in patients with essential hypertension].
Li XL; Xu Q; Tong M; Zhang HF; Zhou YL; Huang J
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):130-3. PubMed ID: 19719988
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma resistin concentrations in patients with liver cirrhosis.
Kakizaki S; Sohara N; Yamazaki Y; Horiguchi N; Kanda D; Kabeya K; Katakai K; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Jan; 23(1):73-7. PubMed ID: 18171344
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and serum fatty acid composition in patients with type 2 diabetes mellitus.
Perassolo MS; Almeida JC; Steemburgo T; Dall'Alba V; de Mello VD; Zelmanovitz T; de Azevedo MJ; Gross JL
Metabolism; 2008 Sep; 57(9):1167-72. PubMed ID: 18702940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
